News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Katsuaki Maehara: Immunotherapy trials in resectable NSCLC
Katsuaki Maehara/X
Jan 29, 2025, 22:05

Katsuaki Maehara: Immunotherapy trials in resectable NSCLC

Katsuaki Maehara, Director of Medical Education Colleagues, posted on X:

“Immunotherapy trials in resectable NSCLC.

Updated clinical data as of January, 2025.

KEYNOTE-671 – 4 year update.”

Katsuaki Maehara: Immunotherapy trials in resectable NSCLC

cancer Katsuaki Maehara NSCLC OncoDaily Oncology
Special Coverage
Blog
Jun 5, 2025, 06:15
Kleida Mati Has Been Awarded a Partial Scholarship to Pursue The Master’s in Molecular Oncology - European School of Oncology
Dialogues
Jun 5, 2025, 06:10
Levi Garraway: Transforming Oncology Through Precision, Resilience And Heart
Blog
Jun 5, 2025, 05:59
A Vibrant Few Days at The ASCO2025 Annual Meeting in Chicago - SPCC
Blog
Jun 5, 2025, 05:45
Alique Topalian: ASCO25 Conference Was a Great Success
Career
Jun 5, 2025, 05:32
Gabriel Aleixo: Honored to Receive Stanley Bradley Award for Clinical Science Research
Blog
Jun 5, 2025, 05:23
Sumanta K. Pal: Insightful Discussion on GU Cancer at ASCO Virtual Meeting Led by Jacqueline T. Brown
Science
Jun 5, 2025, 05:09
Nelson Dusetti: Article on Medical Management of Pancreatic Cancer Just Accepted in Cancer Treatment Reviews
Blog
Jun 5, 2025, 05:05
Javier Martin-Broto and Nadia Hindi Presented at ASCO25 Sarcoma Session
Blog
Jun 5, 2025, 04:52
Tom Powles: Promising Data on Carboplatin/Gemcitabine in M1 Bladder Cancer from EVP
Blog
Jun 5, 2025, 04:41
Mark Middleton Highlights Icon Group and City Cancer Challenge Work on OncoDaily Podcast
Blog
Jun 5, 2025, 04:34
Inimfon Jackson: Grateful to Receive 2025 ASCO YIA and for the Support of My Mentors
Blog
Jun 5, 2025, 04:28
Shameel Shafqat Presents Immunotherapy Research in Recurrent Gliomas at ASCO 2025